Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Analia Mykietiuk
Safety, Resistance, and Efficacy Results From a Phase IIIb Study of Conventional- And Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients
Infectious Diseases and Therapy
Infectious Diseases
Microbiology
Related publications
Efficacy and Safety of Oseltamivir in Treatment and Prevention of Influenza Virus Infection in Patients With Hemodialysis
Nihon Toseki Igakkai Zasshi
Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results From the SPARK Open-Label, Multicentre, Randomized Phase IIIb Trial
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Safety and Efficacy of Pasireotide in Dumping Syndrome-Results From a Phase 2, Multicentre Study
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study
Clinical Therapeutics
Pharmacology
Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study With Vancomycin-Aztreonam
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Erratum to : Efficacy and Safety of the Selective Oral Neuraminidase Inhibitor Oseltamivir for Prophylaxis Against Influenza
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
Efficacy and Safety of Velmanase Alfa in the Treatment of Patients With Alpha-Mannosidosis: Results From the Core and Extension Phase Analysis of a Phase III Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
Journal of Inherited Metabolic Disease
Genetics
Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results From a Randomised Phase 2 Study
British Journal of Dermatology
Dermatology
Medicine
Efficacy and Safety of AR101 in Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
